Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 22 for “"fondaparinux"”.

  1. Predicting binding affinities of a novel polymer for the neutralization of fondaparinux

    … For instance, while the synthetic anticoagulant fondaparinux has become increasingly important in clinical medicine because of its advantages over other heparin-based drugs, its use is limited by a lack of an antidote. The development of an effective, clinically safe antidote for fondaparinux is …

    ubc Repository record for Predicting binding affinities of a novel polymer for the neutralization of fondaparinux (opens in a new tab) Download PDF for Predicting binding affinities of a novel polymer for the neutralization of fondaparinux (opens in a new tab)

  2. Mechanism of Catheter Thrombosis and Approaches for its Prevention

    … only a single clotting enzyme. For example, fondaparinux, a synthetic heparin fragment, only inhibits fXa and dabigatran, an oral thrombin inhibitor, only targets thrombin. Although effective for many indications, fondaparinux was less effective than heparin for preventing clotting on …

    mcmaster Repository record for Mechanism of Catheter Thrombosis and Approaches for its Prevention (opens in a new tab)

  3. Geros laboratorinės praktikos principų taikymas, vykdant gydymo antikoaguliantais stebėseną anti-Xa metodu /

    … characteristics of the test procedures of fondaparinux, rivaroxaban, apixaban and dabigatran, compared to the manufacturer's declared characteristics and, in case of positive results, to implement methods for clinical practice. Methods. An anonymous questionnaire was conducted and 31 …

    vilnius Repository record for Geros laboratorinės praktikos principų taikymas, vykdant gydymo antikoaguliantais stebėseną anti-Xa metodu / (opens in a new tab)

  4. Effects of Glycosaminoglycans on DNase-Mediated Degradation of DNA, DNA-Histone Complexes, and NETs

    … non-anticoagulant heparin), and fondaparinux (the pentasaccharide unit). Using agarose gel experiments, we showed that UFH, enoxaparin, and Vasoflux enhance the ability of DNase I to digest DNA-histone complexes (presumably by displacing DNA from histones), whereas fondaparinux …

    mcmaster Repository record for Effects of Glycosaminoglycans on DNase-Mediated Degradation of DNA, DNA-Histone Complexes, and NETs (opens in a new tab)

  5. Studies of Heparin Variants in Sepsis-Associated Immunothrombosis

    … LMWH, Vasoflux (low-anticoagulant-LMWH), and fondaparinux (ultra-small-LMWH). We used the 48-hour FIP model of abdominal sepsis. In this model, C57BL/6J male and female mice (10-12 weeks old) received an intraperitoneal injection of rat fecal slurry to induce sepsis. Heparins were injected in …

    mcmaster Repository record for Studies of Heparin Variants in Sepsis-Associated Immunothrombosis (opens in a new tab)

  6. Design and development of macromolecular polyanion inhibitors (MPIs) and their evaluation as therapeutics to prevent or treat thrombosis

    … (UFH), low molecular weight heparins (LMWH), fondaparinux), polyanions used to treat thrombosis. The only available antidote is protamine sulfate, which only fully reverses the effects of UFH. Here, a new molecule, MPI 2, is shown to successfully reverse the effects of UFH, LMWH and …

    ubc Repository record for Design and development of macromolecular polyanion inhibitors (MPIs) and their evaluation as therapeutics to prevent or treat thrombosis (opens in a new tab) Download PDF for Design and development of macromolecular polyanion inhibitors (MPIs) and their evaluation as therapeutics to prevent or treat thrombosis (opens in a new tab)

  7. Der Einfluss der Inhibition von Faktor Xa auf die myokardiale Inflammation und die linksventrikuläre Pumpfunktion im Rahmen einer Coxsackievirus B3-induzierten Kardiomyopathie

    … Mäuse wurden mit dem spezifischen FXa-Hemmer Fondaparinux behandelt und entsprechenden Vergleichsgruppen gegenüber gestellt. 8 Tage p.i. wurde die linksventrikuläre Pumpfunktion mittels Konduktanz-Katheter bestimmt. Das Myokardgewebe wurde immunhistologischen, molekularbiologischen und …

    fu-berlin Repository record for Der Einfluss der Inhibition von Faktor Xa auf die myokardiale Inflammation und die linksventrikuläre Pumpfunktion im Rahmen einer Coxsackievirus B3-induzierten Kardiomyopathie (opens in a new tab)

  8. Heparan Sulfate. A Ligand for Coordination Compounds.

    … were then probed in biophysical assays with Fondaparinux (FPX), a commonly used model for HS. As a generality, compounds with increased number of platinum centers, and higher overall charges exhibited higher affinities towards FPX. Additional assays determined the hydrogen bonding abilities …

    vcu Repository record for Heparan Sulfate. A Ligand for Coordination Compounds. (opens in a new tab)

  9. Παθοφυσιολογία, εργαστηριακή διερεύνηση του συνδρόμου ΗΙΤΤ και αντιμετώπιση

    … Χα που είναι κυρίως το Danaparoid και το Fondaparinux. Εκτός της φαρμακευτικής εναλλακτικής αντιπηκτικής αγωγής ( κυρίως χρησιμοποιούνται η Λεπιρουδίνη, το Danaparoid και το Fondaparinux)μπορεί να χρησιμοποιηθούν και συμπληρωματικές θεραπείες, όπως η θρομβόλυση, η εμβολεκτομή, το φίλτρο …

    athens Repository record for Παθοφυσιολογία, εργαστηριακή διερεύνηση του συνδρόμου ΗΙΤΤ και αντιμετώπιση (opens in a new tab)

  10. Assessment of venous thromboembolism prophylaxis in a South African private hospital group

    … measures where enoxaparin (89.09%) and fondaparinux (2.68%). Prophylactic measures differed per geographical location and speciality - with the highest use in the Tshwane region and most compliant amongst intensivists. Conclusions: Less than 24.56% of patients who required prophylaxis …

    nwu-za Repository record for Assessment of venous thromboembolism prophylaxis in a South African private hospital group (opens in a new tab)

  11. Πρόληψη της θρομβοεμβολικής νόσου στους ορθοπαιδικούς ασθενείς

    … μοριακού βάρους, ο συνθετικός πεντασακχαρίτης Fondaparinux, και τα νεώτερα από του στόματος αντιπηκτικά: Dabigatran, Rivaroxaban, Apixaban. Το Αμερικάνικο Κολλέγιο Πνευμονολόγων έχει θεσπίσει κατευθυντήριες οδηγίες για την πρόληψη της ΘΕΝ στους ορθοπαιδικούς ασθενείς. Οι οδηγίες αυτές αφορούν …

    athens Repository record for Πρόληψη της θρομβοεμβολικής νόσου στους ορθοπαιδικούς ασθενείς (opens in a new tab)

  12. Ūmus miokardo infarktas ir heparino sukelta trombocitopenija /

    … and factor Xa inhibitors (danaparoid, fondaparinux), but direct oral anticoagulants are also increasingly described in the literature. Conclusions. Heparin-induced thrombocytopenia is a life-threatening phenomenon of an immune response. Due to a higher risk of developing the disease, …

    vilnius Repository record for Ūmus miokardo infarktas ir heparino sukelta trombocitopenija / (opens in a new tab)

  13. AN IN VITRO MODEL TO EVALUATE THE EFFECTS OF ANTICOAGULANTS ON CLOT FORMATION IN THE PRESENCE OF LOW PLATELET COUNTS

    … unfractionated heparin (UFH), dalteparin, fondaparinux, rivaroxaban or dabigatran. We found clotting had different sensitivity to TF concentration depending on the anticoagulant present. Effects on TEG parameters varied at a fixed TF concentration with each anticoagulant. UFH had the …

    mcmaster Repository record for AN IN VITRO MODEL TO EVALUATE THE EFFECTS OF ANTICOAGULANTS ON CLOT FORMATION IN THE PRESENCE OF LOW PLATELET COUNTS (opens in a new tab)

  14. Structural and Dynamic Basis of Platelet Factor 4 Antigenicity as Revealed by Solution NMR

    … effects. In Chapter 4, we map how binding of the fondaparinux remodels the PF4 conformational landscape, extending the lifetime of exposed PF4 epitopes and enhancing their long‑range μs-ms dynamics. Finally, Chapter 5 summarizes key conclusions from previous chapters and outlines future directions …

    mcmaster Repository record for Structural and Dynamic Basis of Platelet Factor 4 Antigenicity as Revealed by Solution NMR (opens in a new tab)

  15. Venous Thromboembolism Prevention in the Bariatric Surgical Patient: Are we doing enough?

    … twice daily (our standard regimen), and fondaparinux 5 mg subcutaneously once daily (a non-standard dose in the obese population, used under an IND obtained by Dr. Steele). We used MRV as a novel non-invasive diagnostic tool to detect asymptomatic DVT in our patient population (Chapter …

    jhu Repository record for Venous Thromboembolism Prevention in the Bariatric Surgical Patient: Are we doing enough? (opens in a new tab)

  16. Metalloglycomics: Investigating the Interactions of Metal Complexes with Heparan Mimetics

    … inhibition of the model pentasaccharide, Fondaparinux, by bacterial Heparinase. Such metalloshielding by PPCs may also protect HS from enzymatic cleavage by the mammalian heparanase; preventing growth factors from binding to HS and/or preventing release of bound growth factors and thus …

    vcu Repository record for Metalloglycomics: Investigating the Interactions of Metal Complexes with Heparan Mimetics (opens in a new tab)

  17. Management of Superficial Venous Thrombosis: A Systematic Review of Literature and Survey of Canadian Physicians

    … findings of our meta-analysis identified that Fondaparinux, at prophylactic dose, to had the lowest event rate of 2.0 events per 100 patient years of follow-up (95% CI 0.4 to 4.7, I2=33%) for the primary outcome of deep vein thrombosis (DVT) or pulmonary embolism (PE) during follow-up. Pooled …

    ottawa-retro Repository record for Management of Superficial Venous Thrombosis: A Systematic Review of Literature and Survey of Canadian Physicians (opens in a new tab)

  18. Heparan Sulfate, A New Target for Platinum in Metastatic TNBC

    … we report PPC interactions with HS-like models: Fondaparinux (FPX)3 and heparin4. We demonstrate TriplatinNC high affinity to heparin in biophysical studies and compare HS interactions with DNA and HS using competition assays.3,4 these approaches may be extended to a range of metal-ammine …

    vcu Repository record for Heparan Sulfate, A New Target for Platinum in Metastatic TNBC (opens in a new tab)

Page 1 of 2